Corcept Therapeutics, Inc. (CORT)
34.01
-1.68
(-4.71%)
USD |
NASDAQ |
Mar 05, 16:00
34.30
+0.29
(+0.85%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow : 141.78M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Axsome Therapeutics, Inc. | -93.88M |
| United Therapeutics Corp. | 1.035B |
| Harrow, Inc. | 42.76M |
| Ultragenyx Pharmaceutical, Inc. | -487.00M |
| Amneal Pharmaceuticals, Inc. | 225.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 38.45M |
| Cash from Investing (Quarterly) | -11.84M |
| Cash from Financing (Quarterly) | -31.22M |
| Free Cash Flow Per Share (Quarterly) | 0.3204 |
| Free Cash Flow to Equity (Quarterly) | 38.65M |
| Free Cash Flow to Firm (Quarterly) | 38.40M |
| Free Cash Flow Yield | 3.48% |